• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1476 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 Malaysian Health Technology Assessment (MaHTAS) Pulse oximetry screening for critical congenital heart disease in newborn infants
2014 Malaysian Health Technology Assessment (MaHTAS) Inexscreen as a screening test for ectopic pregnancy and miscarriage
2014 Malaysian Health Technology Assessment (MaHTAS) Screening of pregnant women aged 40 years old and above for cardiac abnormalities using electrocardiography (ECG) to prevent maternal mortality
2014 Malaysian Health Technology Assessment (MaHTAS) OncoE6TM cervical screening test kit
2014 Malaysian Health Technology Assessment (MaHTAS) Infrared regulation thermography for cancer
2014 Andalusian Health Technology Assessment Area (AETSA) Digital tomosynthesis in breast cancer. Systematic Review
2014 Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2014 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of an HPV test in primary screening for cervical cancer - Rapid report]
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) HPV OncoTect E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Neonatal screening for lysosomal storage disorders
2014 Canary Health Service [Cost-effectiveness of neonatal screening for very long chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2014 Canary Health Service [Cost-effectiveness of neonatal screening for primary carnitine deficiency]
2014 Canary Health Service [Surgical treatment of benign melanocytic lesions for the prevention of melanoma]
2013 Agency for Healthcare Research and Quality (AHRQ) Pulmonary arterial hypertension: screening, management, and treatment
2013 The Netherlands Organisation for Health Research and Development (ZonMw) [Pharmacogenetic testing in the clinical setting: is screening for TPMT genotype a cost-effective treatment strategy? The first prospective randomized controlled trial within the Dutch health care system]
2013 NIHR Health Technology Assessment programme AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013 NIHR Health Technology Assessment programme Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
2013 NIHR Health Technology Assessment programme Systematic review of the psychological consequences of false-positive screening mammograms
2013 NIHR Health Technology Assessment programme Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Newborn screening for cystic fibrosis. Efficacy/ effectiveness and implementation protocols]
2013 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of fetal alcohol syndrome]
2013 NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
2013 NIHR Health Technology Assessment programme Screening for type 2 diabetes: a short report for the National Screening Committee
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Advisability of expanding the Québec newborn blood screening program]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening of sickle cell anemia]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Automated reading methods of uterine cervical cytology]
2013 Agency for Healthcare Research and Quality (AHRQ) Efficacy and safety of screening for postpartum depression
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013 HAYES, Inc. Interleukin 28B (IL28B) testing to predict response to treatment of hepatitis C virus (HCV) infection
2013 Penn Medicine Center for Evidence-based Practice (CEP) Urine drug screening in chronic pain patients on opioid therapy
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013 National Evidence-based Healthcare Collaborating Agency (NECA) [Cost-effectiveness of human papillomavirus vaccination in South Korea]
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme - Part IX: Evidence-based screening guidelines for pregnant women and children (0 – 6 yrs.)]
2013 HAYES, Inc. Low-dose helical (spiral) computed tomography for lung cancer screening
2013 HAYES, Inc. Cystic Fibrosis Transmembrane Regulator (CFTR) testing for cystic fibrosis
2013 Blue Cross Blue Shield Association (BCBS) Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force.
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2013 Agency for Healthcare Research and Quality (AHRQ) The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction in asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013 HAYES, Inc. Noninvasive Prenatal Testing (NIPT) for fetal aneuploidy
2013 Institute of Health Economics (IHE) Transcutaneous bilirubinometry for the screening of neonatal hyperbilirubinemia ≥35 weeks' gestation
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [P16/Ki-67 dual stain in the triage of PAPIII/IIID cytology in cervical cancer screening]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test]
2013 Health Quality Ontario (HQO) Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2013 Health Quality Ontario (HQO) Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for sexually transmitted infections: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prioritizing patients undergoing non-urgent, medically necessary cosmetic surgical procedures: clinical evidence and guidelines
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Preimplantation genetic screening (PGS) in patients undergoing high-complexity reproduction technologies]
2013 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for the diagnosis of breast cancer]
2013 HAYES, Inc. Phenylalanine hydroxylase (PAH) deficiency (including phenylketonuria [PKU])
2013 HAYES, Inc. Prolaris test for prediction of prostate cancer progression
2013 NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prostate cancer screening: a review of the guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal screening procedures prior to physician visits: guidelines
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: mammography in two directions as standard
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: calcium score and the risk of cardiovascular disease
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: national population screening programme for bowel cancer
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: Continuing a population screening trial
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: bowel cancer screening by pill camera
2013 Health Council of the Netherlands Gezondheidsraad (GR) NIPT: dynamics and ethics of prenatal screening
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2013 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013 Health Quality Ontario (HQO) Role of screening for respiratory syncytial virus or influenza and empirical antiviral treatment for patients with community-acquired pneumonia: a rapid review
2013 Blue Cross Blue Shield Association (BCBS) Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21
2013 Medical Services Advisory Committee (MSAC) Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013 Malaysian Health Technology Assessment (MaHTAS) NH2 Drug Lab (DRUGKOP)
2013 Basque Office for Health Technology Assessment (OSTEBA) [Models of collaboration and intervention between primary care and mental health in the care of patients diagnosed with depression: results of a meta-review]
2013 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for classical galactosemia]
2013 Canary Health Service [Cost-effectiveness of neonatal screening for tyrosemia type I]
2013 Canary Health Service [Cost-effectiveness of newborn screening for sickle cell anemia]
2012 NIHR Health Technology Assessment programme Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of screening and treatment of high-risk fracture patients by an osteoporosis nurse-practitioner]
2012 NIHR Health Technology Assessment programme Screening for cystic fibrosis-related diabetes: a systematic review
2012 Belgian Health Care Knowledge Centre (KCE) Hepatitis C screening and prevention
2012 NIHR Horizon Scanning Centre (NIHR HSC) HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening
2012 NIHR Horizon Scanning Centre (NIHR HSC) DELFIA® Xpress PlGF kit antenatal screening test to predict risk of pre-eclampsia
2012 HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2012 Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for aspiration and dysphagia
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part V: Preterm birth]
2012 HAYES, Inc. Septin 9 (SEPT9) methylation analysis for colorectal cancer
2012 HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012 Institute of Health Economics (IHE) First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects
2012 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of genetic tests for screening of colorectal cancer]